Archives
PKM2 Inhibitor Compound 3k: Evidence Overview
2026-10-09
A source-grounded overview of PKM2 inhibitor (compound 3k), covering its proposed metabolic mechanism, reported findings in severe acute pancreatitis and cancer models, evidence provenance, conceptual applications, and key limitations.
Enhanced EZ Cap™ EGFP mRNA: Evidence Guide
2026-10-08
Enhanced EZ Cap™ EGFP mRNA (m1Ψ) can serve as a reporter cargo for studying RNA delivery, but its fluorescence must be interpreted as a multi-step biological readout. This evidence-focused guide connects reporter mRNA design with the 2025 potato virus X nucleoprotein platform study while defining what the findings do—and do not—establish.
From EGFP Editing to Translational Confidence
2026-10-08
Multiplexed CRISPR is moving from a technical capability to a question of evidence quality. Using EGFP-targeting reagents in HeLa as a model system, this article examines mechanistic rationale, validation logic, translational boundaries, and how researchers can interpret multiplexed editing without confusing a visible reporter response with genome-engineering certainty.
Mitochondrial Remodeling: From PFKM to ER Signaling
2026-10-07
A translational interpretation of how PFKM links glycolytic state, ER–mitochondria communication, and mitochondrial quality control during osteogenesis. The article also explains where an ER-focused fluorescent mRNA probe can add biological context without overstating what it can measure.
Adamtsl3, MMP9, and Adult Cortical Plasticity
2026-10-07
A 2026 Molecular Psychiatry study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons. Mouse genetic, imaging, biochemical, rescue, and plasticity evidence links Adamtsl3 loss to excess MMP9 activity, reduced Otx2 uptake, oxidative stress, and renewed juvenile-like cortical plasticity.
MRSA EVs and IL-8-Dependent OSCC Growth
2026-10-06
A 2026 study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma proliferation, distinguishing their effects from vesicles produced by methicillin-susceptible S. aureus. The reported ERK/c-Jun–IL-8–CXCR1 signaling relationship broadens the study of antibiotic-resistant bacteria in cancer biology while remaining limited by preclinical models and unresolved pathway details.
ZCL278 and Cdc42: Evidence and Research Context
2026-10-06
A source-grounded overview of ZCL278 as a reported selective Cdc42 inhibitor, its relevance to cell motility and neuronal morphology, and why recent kidney-fibrosis findings with daphnepedunin A should not be interpreted as direct evidence for ZCL278.
SINAT–VAB1 Control of Plant Autophagy
2026-10-05
A 2026 Arabidopsis study identifies VAB1, a V-ATPase subunit, as a direct SINAT-associated regulator of autophagic vesicle degradation. The findings connect SINAT-dependent ubiquitination of VAB1 with vacuolar acidification, nutrient-starvation tolerance, and leaf senescence, extending plant autophagy research beyond autophagosome formation.
Ac-YVAD-CMK in Caspase-1 and Liver Inflammation
2026-10-05
Ac-YVAD-CMK, also known as N-Ac-Tyr-Val-Ala-Asp-CMK, is commonly described as a caspase-1-targeting research compound. This overview places that pharmacological claim alongside a 2024 mouse study showing that Kupffer-cell TMEM16F protects against Listeria-associated liver injury. The evidence supports a conceptual separation of cytokine maturation, membrane repair, and inflammatory cell death, but does not establish that Ac-YVAD-CMK was tested in the study or that it would reproduce its genetic findings.
Dyngo-4a in LNP T Cell Engineering
2026-10-04
Dyngo-4a offers a mechanistic lens for distinguishing nanoparticle uptake, vesicle scission, intracellular trafficking, and productive mRNA expression in engineered T cells. This article interprets recent serial LNP-mRNA findings while defining what dynamin inhibition can—and cannot—demonstrate.
EGFP mRNA m1Ψ in In Vivo Editing Research
2026-10-03
A source-grounded overview of how EGFP mRNA m1Ψ can function as a conceptual reporter for delivery and protein expression research, while distinguishing reporter evidence from the therapeutic findings reported for TELMO mRNA lipid nanoparticles in a murine colitis study.
TMJ Inflammation, Nr4a1, and Hippocampal Synapse Loss
2026-10-02
This study identifies a mechanistic pathway linking temporomandibular joint inflammation to depression-like behaviors through hippocampal microglial Nr4a1 deficiency, neuronal C3 accumulation, and excessive synaptic pruning. Its intervention-based design positions Nr4a1 and C3 as experimentally testable nodes connecting peripheral inflammation with central synaptic remodeling.
RNA Pol II Inhibition Activates Regulated Apoptosis
2026-10-01
Harper et al. show that RNA polymerase II inhibition kills cells through active apoptotic signaling triggered by loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional shutdown and passive mRNA decay. Their PDAR framework provides a mechanistic basis for interpreting transcription-targeting drugs and designing experiments that distinguish polymerase loss from loss of transcription.
tiRNA: Controllable Gene Silencing by Translation Inhibition
2026-10-01
The reference study introduces translation inhibition RNA (tiRNA), an aptamer-based steric-blocking strategy that targets the 5′ untranslated region of selected mRNAs while engaging eIF4G. Its reported combination of siRNA-like silencing, limited reliance on RNA degradation, and neutralizing-strand reversibility presents a controllable framework for regulating protein overexpression.
Ferrostatin-1 (Fer-1) in Ferroptosis Assays
2026-09-30
Ferrostatin-1 (Fer-1) provides a practical rescue control for distinguishing lipid peroxidation-driven death from nonspecific cytotoxicity. This guide translates recent melanocyte ferroptosis findings into executable workflows for cancer biology research, neurodegenerative disease models, and other oxidative injury systems.